Podcast: Gene editing and public acceptance — Agricultural economist Brandon McFadden on regulatory differences in agriculture and medicine for using CRISPR

Gene editing with CRISPR/Cas, TALEN or other tools allows scientists to make directed and precise changes in DNA.  The technologies promise to transform agriculture and medicine. But the application of these technologies hinges on consumer sentiment. Brandon McFadden is an agricultural economist at the University of Delaware who specializes in understanding the intersection between food, agriculture and human behavior. We have a conversation about gene editing, public sentiment, and how it varies between agriculture and medicine.

Brandon McFadden is an agricultural economist at the University of Delaware. Find Brandon on Twitter @mcfaddenagecon

Kevin M. Folta is a professor, keynote speaker and podcast host. Follow Professor Folta on Twitter @kevinfolta

This podcast was originally posted at Talking Biotech and is reposted here with permission. You can follow Talking Biotech on Twitter @talkingbiotech